KILL Dr. Charles Howe of the Mayo Clinic’s Neuroimmunology Department to Join Aditxt Weekly Update on May 2, 2025, to Discuss Newly Announced Preclinical Study Results Sponsored by Aditxt’s Subsidiary Adimune™

Aditxt, Inc. requests that their press release NewsItemId: 20250417385764 “Dr. Charles Howe of the Mayo Clinic’s Neuroimmunology Department to Join Aditxt Weekly Update on May 2, 2025, to Discuss Newly Announced Preclinical Study Results Sponsored by Aditxt’s Subsidiary Adimune™” be killed.

The release was issued in error by Aditxt, Inc..

A replacement release will not be issued at this time.

Contacts

Aditxt, Inc.

Corporate Communications

Jeff Ramson, PCG Advisory, Inc.

T: 646-863-6893

contactus@aditxt.com

More News

View More

Recent Quotes

View More
Symbol Price Change (%)
AMZN  232.99
-5.63 (-2.36%)
AAPL  276.49
+7.01 (2.60%)
AMD  200.19
-41.92 (-17.31%)
BAC  55.38
+0.93 (1.71%)
GOOG  333.34
-7.36 (-2.16%)
META  668.99
-22.71 (-3.28%)
MSFT  414.19
+2.98 (0.72%)
NVDA  174.19
-6.15 (-3.41%)
ORCL  146.67
-8.00 (-5.17%)
TSLA  406.01
-15.95 (-3.78%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.